Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (214)

1

Successful Management of Ovarian Cancer Progressing on Olaparib by Niraparib Following Cytoreduction : A Case Report

enthalten in: In vivo (Athens, Greece) | 2024

von Endo, Y. | Kamo, N. | Kato, A. | +5

2

NRG-GY012 : Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer

enthalten in: Cancer | 2024

von Rimel, B. | Enserro, D. | Bender, D. | +10

3

The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer

enthalten in: International journal of technology assessment in health care | 2024

von Teppala, S. | Scuffham, P. | Tuffaha, H.

4

Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer

enthalten in: Gynecologic oncology | 2024

von Kim, J. | Kim, S. | Park, E. | +5

5

Promising Response of Olaparib in Patient With Germline ATM-Mutated Metastatic Gastric Cancer

enthalten in: Journal of investigative medicine high impact case reports | 2024

von Chan, K. | Rutazanaa, D. | Wray, C. | +3

6

Development of a simple high-performance liquid chromatography-ultraviolet detection method for olaparib in patients with ovarian cancer

enthalten in: Drug discoveries & therapeutics | 2024

von Yasu, T. | Nishijima, R. | Ikuta, R. | +2

7

PRIMA-1 synergizes olaparib-induced cell death in p53 mutant triple negative human breast cancer cell line via restoring p53 function, arresting cell cycle, and inducing apoptosis

enthalten in: Canadian journal of physiology and pharmacology | 2024

von Zaza, M. | Rashed, M. | Elrefaey, H. | +3

8

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38) : a phase IIIb trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Pujade-Lauraine, E. | Selle, F. | Scambia, G. | +21

CommentOn: Ann Oncol. 2023 Dec;34(12):1074-1076. - PMID 38072509

9

PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer

enthalten in: International journal of molecular sciences | 2023

von Ghosh, M. | Kang, M. | Katuwal, N. | +5

10

Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinoma

enthalten in: Molecular carcinogenesis | 2023

von Bitler, B. | Bailey, C. | Yamamoto, T. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]